Amgen's results from its Phase 3 Tower study evaluating Blincyto’s efficacy have been published in the New England Journal of Medicine. Read More »

Merck & Co. Inc. recently released the results of its Phase 3 clinical study of letermovir, a drug used to prevent clinically significant cytomegalovirus infection in CMV-seropositive adult recipients of an allogeneic hematopoietic stem cell transplant, also known as bone marrow transplant. Read More »

Sandoz, a division of Novartis, has selected six finalists for the Sandoz HACk Healthcare Access Challenge. Read More »

Biogen has entered into a licensing agreement for BMS-986168 with Bristol-Myers Squibb to initiate Phase II studies for the antibody treatment for Alzheimer’s disease and progressive supranuclear palsy. Read More »

AbbVie shared the successful results of its Phase IIb clinical trial on elagolix on patients suffering from heavy menstrual bleeding due to fibroids last week. Read More »

Tocagen Inc. recently announced that its Toca 511 & Toca FC drug received Breakthrough Therapy Designation from the U.S. Food and Drug Administration. Read More »

Shire plc recently delivered data at the American Academy of Allergy, Asthma & Immunology annual meeting on its Cuvitru drug, which treats patients with primary immunodeficiency. Read More »

Sanofi and Regeneron Pharmaceuticals Inc.'s Dupixent injection has been approved by the U.S. Food and Drug Administration (FDA) for use treating adults with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies. Read More »

The Truth Initiative and CVS Health Foundation have launched an initiative to combat tobacco use at historically black colleges and universities (HBCUs). Read More »

The voluntary recall of select lots of EpiPen Auto-Injectors and EpiPen Jr devices has been expanded. Read More »

Praising President Donald Trump’s recent executive order to redirect the previous administration’s energy regulations, a spokesman for the grassroots Americans for Prosperity (AFP) has issued a statement of support. Read More »

Sanofi and Regeneron Pharmaceuticals recently presented Phase 3 Chronos study results at the late-breaking oral abstract session of the Annual Meeting of the American Academy of Dermatology. Read More »

Alcon, a division of Novartis, has received approval from the U.S. Food and Drug Administration for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with ActiveFocus optical design. The product was made for patients with an astigmatism and presbyopia who want to treat them both at the same time with cataract surgery. Read More »

Genentech's Ocrevus, the only medicine capable of treating both relapsing and primary progressive forms of multiple sclerosis, has been approved by the U.S. Food and Drug Administration. Read More »

Pharmacists and the difficult balance they must keep between patients suffering from chronic pain and the prevalence opioid abuse was the topic of a recent special issue of the Journal of the American Pharmacists Association Read More »

McKesson, the platinum sponsor of CBI’s Formulary, Co-Pay and Access Summit is presenting a new approach to patient-centric behavioral coaching with the overall goal of improving adherence despite affordability and other barriers. Read More »

Prescription drug costs battles are far from over as PCMA calls for the drug lobby to stop deflecting blame in an effort to maintain profit margins. Read More »

Biologics Inc., which is owned by McKesson Specialty Health, has been chosen as the exclusive specialty pharmacy provider for BAVENCIO (avelumab). Read More »

Daiichi Sankyo Inc.has sold its pharmaceutical packaging plant in Bethlehem, Pennsylvania to Sharp Packaging Services, a division of UDG Healthcare. Read More »

The U.S. Food and Drug Administration (FDA) has granted Bristol-Myers Squibb Co. a priority review for the company’s Opdivo Biologics License Application. Read More »